XELOX stop-and-go trial:A phase 2 study of 1st line chemotherapy for unresectable or recurrent colorectal cancer.
Phase of Trial: Phase II
Latest Information Update: 11 Mar 2011
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 11 Mar 2011 New trial record